Capnography Devices Industry Overview

The global capnography devices market size was valued at USD 676.6 million in 2023 and is projected to grow at a CAGR of 10.0% from 2024 to 2030.

Expected advancements in technology, the increasing occurrence of respiratory conditions, and backing from government programs will enhance market expansion throughout the projected period. Attributed to its superior reliability and effectiveness, the rising use of capnography for managing respiratory illnesses is forecasted to enhance the clinical performance of these devices in monitoring patients. For instance, in 2022, 4.6% of adults were reported to have received a diagnosis of COPD, emphysema, or chronic bronchitis at some point. Office-based physician visits where COPD was noted in the medical records accounted for 4.2%. There were approximately 791,000 emergency department visits where COPD was the main reason for the visit.

Gather more insights about the market drivers, restrains and growth of the Capnography Devices Market

Technological advancements in capnography, including the development of portable and handheld devices, improved accuracy, and seamless integration with other monitoring systems, significantly drive market growth by enhancing usability and expanding application areas. For instance, in June 2022, clinicians could further personalize care with Medtronic’s integration of INVOS regional oximetry (rSO2) and Microstream capnography (CO2) technologies. These continuous monitoring solutions became available on the GE Healthcare CARESCAPE precision monitoring platform, enhancing perioperative and ICU care.

The increasing number of surgeries, especially those involving anesthesia, drives the demand for capnography devices. These devices are essential for monitoring CO2 levels during procedures, ensuring patient safety and effective anesthesia management. According to the International Society of Aesthetic Plastic Surgery, approximately 310 million major surgeries are conducted annually, with 20 million in Europe and 40 to 50 million in the U.S. In 2022, the U.S. led with over 7.4 million procedures, followed by Brazil (8.9%) and Japan (7.3%). Most surgeries occur in hospitals (47.4%) or office facilities (31.1%) worldwide.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global energy-based aesthetic devices market sizewas estimated at USD 6.36 billion in 2023 and is projected to grow at a CAGR of 14.2% over the forecast period.
• The global orthopedic splints market sizewas valued at USD 1.69 billion in 2023 and is expected to grow at a CAGR of 9.7% from 2024 to 2030. 

Capnography Devices Market Segmentation

Grand View Research has segmented the global capnography devices market based on component, technology, application, type, end use, and region:

Capnography Devices Component Outlook (Revenue, USD Million, 2018 - 2030)

• OEM Modules
• Others

Capnography Devices Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Mainstream
• Sidestream
• Microstream

Capnography Devices Application Outlook (Revenue, USD Million, 2018 - 2030)

• Emergency Medicine
• Pain Medicine
• Procedural Sedation
• Critical Care
• Others

Capnography Devices Type Outlook (Revenue, USD Million, 2018 - 2030)

• Hand-held
• Stand-alone
• Multi-parameter

Capnography Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Ambulatory Care Centers
• Others

Capnography Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Russia
• Asia Pacific
  • China
  • India
  • New Zealand
  • Singapore
  • Japan
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa      
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Key Companies profiled:

• Smiths Medical (acquired by ICU Medical Inc.)
• Dragerwerk AG & Co. KGaA
• Baxter
• Masimo
• Koninklijke Philips N.V.
• Medtronic
• Nonin
• NIHON KOHDEN CORPORATION
• BD
• Diamedica (UK) Limited
• EDAN Instruments, Inc.

Key Capnography Devices Company Insights

Some of the key companies in the capnography devices market include Smiths Medical (acquired by ICU Medical Inc.), Dragerwerk AG & Co. KGaA, Baxter, Masimo, Koninklijke Philips N.V., Medtronic, Nonin, NIHON KOHDEN CORPORATION, BD, Diamedica (UK) Limited, and EDAN Instruments, Inc. Organizations are focusing on increasing customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions, and partnerships with other major companies.

• Smiths Medical, a division of the UK-based Smiths Group plc, is a global manufacturer of specialty medical devices serving various healthcare sectors such as critical care, anesthesia, and oncology. The company operates in over 50 countries and markets its products to more than 100 countries, catering to hospitals, clinics, and home care settings.
• Dragerwerk AG & Co. KGaA is an international company specializing in medical and safety technology, offering neonatal, intensive, prenatal, and emergency care solutions. Their product range includes monitoring, ventilation, anesthetics, warming therapy, and information management systems.

Recent Developments

• In January 2023, Koninklijke Philips N.V. and Masimo extended their collaboration to enhance global telehealth. Through innovative technologies and solutions, they aim to improve healthcare experiences for patients and clinicians. This partnership seeks to advance remote patient monitoring and telehealth services on a global scale.
• In January 2022, ICU Medical Inc. acquired Smiths Medical from Smiths Group plc, incorporating a diverse product range, including syringes, vascular access, ambulatory infusion devices, and vital care solutions.

Order a free sample PDF of the Capnography Devices Market Intelligence Study, published by Grand View Research.